NCT00022880View on ClinicalTrials.gov

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

PHASE1UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 31, 1999

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG

Iodine-131 Anti-B1 Antibody

Trial Locations (2)

11041

Long Island Jewish Medical Center, New Hyde Park

94305

Stanford University Medical Center, Palo Alto

Sponsors

Lead Sponsor

Corixa Corporation

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Corixa Corporation

INDUSTRY